QuidelOrtho (QDEL) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
16 Jun, 2026Opening remarks and agenda
Meeting called to order at 8:30 A.M. Pacific Time and conducted virtually to increase accessibility and reduce costs.
Agenda and rules of conduct were made available to attendees via the web portal.
Attendees included board members, executive officers, auditors from KPMG, and outside legal counsel.
Board and executive committee updates
Board members and executive officers were introduced, including the CEO, CFO, and VP of Investor Relations.
Chief Legal Officer and Corporate Secretary, as well as representatives from KPMG and outside counsel, were present.
Shareholder proposals
Three proposals were presented: election of 10 directors, advisory approval of executive compensation, and ratification of KPMG as auditor for 2026.
Stockholders were invited to comment or ask questions on the proposals via the web portal.
Latest events from QuidelOrtho
- Cost savings, product launches, and regional recoveries drive growth amid China pricing reset.QDEL
Jefferies Global Healthcare Conference 20263 Jun 2026 - Diagnostics innovation and operational focus drive recurring revenue and profitability growth.QDEL
46th Annual William Blair Growth Stock Conference2 Jun 2026 - Q1 2026 revenue fell 10.5–13% with a $92M net loss and lower full-year guidance.QDEL
Q1 20266 May 2026 - Shareholders will vote on directors, executive pay, and auditor ratification, with strong governance and ESG focus.QDEL
Proxy filing27 Apr 2026 - Key votes include director elections, executive pay, and auditor ratification at the 2026 meeting.QDEL
Proxy filing27 Apr 2026 - FY26 revenue guidance of $2.9B and margin expansion driven by innovation and recurring revenue.QDEL
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - 2025 saw margin expansion and strong Labs growth, with FY26 guidance projecting higher cash flow.QDEL
Q4 202512 Feb 2026 - Q2 revenue fell, but recurring revenue rose 5% as cost savings and impairments shaped results.QDEL
Q2 20242 Feb 2026 - Q1 2024 saw 6% revenue growth ex-COVID-19, with margin focus and global expansion initiatives.QDEL
The 44th Annual William Blair Growth Stock Conference1 Feb 2026